Effect of Daratumumab combined with Chemotherapy on Immune Function in Patients with Relapsed/Refractory Multiple Myeloma and Observation of its Clinical Efficacy

OBJECTIVE: To evaluate the clinical efficacy and immune function of Daratumumab combined with chemotherapy in patients with relapsed/refractory multiple myeloma (RRMM). METHODS: Eighty patients with RRMM treated in Xingtai People’s Hospital from January, 2020 to December, 2021 were randomly divided...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ye-hua, Xu, Feng, Xu, Chang-qing, Zhang, Zi-tan, Jiao, Zong-jiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843002/
https://www.ncbi.nlm.nih.gov/pubmed/36694744
http://dx.doi.org/10.12669/pjms.39.1.6667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843002/
https://www.ncbi.nlm.nih.gov/pubmed/36694744
http://dx.doi.org/10.12669/pjms.39.1.6667

Ejemplares similares